GLUDP5

Glutamate dehydrogenase pseudogene 5, also known as GLUDP5, is a human gene.[2]

GLUD1P5
Identifiers
Aliases	GLUD1P5, GLUDP5, glutamate dehydrogenase 1 pseudogene 5
External IDs	GeneCards: GLUD1P5
Orthologs
Species	Human	Mouse
Entrez	2751	n/a
Ensembl	n/a	n/a
UniProt	n/a	n/a
RefSeq (mRNA)	n/a	n/a
RefSeq (protein)	n/a	n/a
Location (UCSC)	n/a	n/a
PubMed search	[1]	n/a
Wikidata
View/Edit Human

References

1. "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
2. "Entrez Gene: GLUDP5 glutamate dehydrogenase pseudogene 5".

Further reading

• Meissner T, Beinbrech B, Mayatepek E (1999). "Congenital hyperinsulinism: molecular basis of a heterogeneous disease". Hum. Mutat. 13 (5): 351–61. doi:10.1002/(SICI)1098-1004(1999)13:5<351::AID-HUMU3>3.0.CO;2-R. PMID 10338089.
• Julliard JH, Smith EL (1979). "Partial amino acid sequence of the glutamate dehydrogenase of human liver and a revision of the sequence of the bovine enzyme". J. Biol. Chem. 254 (9): 3427–38. PMID 429360.
• Hochstrasser DF, Frutiger S, Paquet N, et al. (1993). "Human liver protein map: a reference database established by microsequencing and gel comparison". Electrophoresis. 13 (12): 992–1001. doi:10.1002/elps.11501301201. PMID 1286669.
• Mavrothalassitis G, Tzimagiorgis G, Mitsialis A, et al. (1988). "Isolation and characterization of cDNA clones encoding human liver glutamate dehydrogenase: evidence for a small gene family". Proc. Natl. Acad. Sci. U.S.A. 85 (10): 3494–8. doi:10.1073/pnas.85.10.3494. PMC 280238. PMID 3368458.
• Amuro N, Yamaura M, Goto Y, Okazaki T (1988). "Molecular cloning and nucleotide sequence of the cDNA for human liver glutamate dehydrogenase precursor". Biochem. Biophys. Res. Commun. 152 (3): 1395–400. doi:10.1016/S0006-291X(88)80440-6. PMID 3377777.
• Nakatani Y, Schneider M, Banner C, Freese E (1988). "Complete nucleotide sequence of human glutamate dehydrogenase cDNA". Nucleic Acids Res. 16 (13): 6237. doi:10.1093/nar/16.13.6237. PMC 336872. PMID 3399399.
• Nakatani Y, Banner C, von Herrath M, et al. (1988). "Comparison of human brain and liver glutamate dehydrogenase cDNAS". Biochem. Biophys. Res. Commun. 149 (2): 405–10. doi:10.1016/0006-291X(87)90381-0. PMID 3426581.
• Banner C, Silverman S, Thomas JW, et al. (1987). "Isolation of a human brain cDNA for glutamate dehydrogenase". J. Neurochem. 49 (1): 246–52. doi:10.1111/j.1471-4159.1987.tb03422.x. PMID 3585334.
• Tzimagiorgis G, Leversha MA, Chroniary K, et al. (1993). "Structure and expression analysis of a member of the human glutamate dehydrogenase (GLUD) gene family mapped to chromosome 10p11.2". Hum. Genet. 91 (5): 433–8. doi:10.1007/BF00217767. PMID 8314555.
• Goulielmos G, Angelicheva D, Kapsetaki M, et al. (1993). "A chromosome 10p11.2 Gt-dinucleotide repeat polymorphism at the GLUDP5 gene locus". Hum. Mol. Genet. 2 (8): 1328. doi:10.1093/hmg/2.8.1328-a. PMID 8401522.
• Michaelidis TM, Tzimagiorgis G, Moschonas NK, Papamatheakis J (1993). "The human glutamate dehydrogenase gene family: gene organization and structural characterization". Genomics. 16 (1): 150–60. doi:10.1006/geno.1993.1152. PMID 8486350.
• Stanley CA, Lieu YK, Hsu BY, et al. (1998). "Hyperinsulinism and hyperammonemia in infants with regulatory mutations of the glutamate dehydrogenase gene". N. Engl. J. Med. 338 (19): 1352–7. doi:10.1056/NEJM199805073381904. PMID 9571255.
• Miki Y, Taki T, Ohura T, et al. (2000). "Novel missense mutations in the glutamate dehydrogenase gene in the congenital hyperinsulinism-hyperammonemia syndrome". J. Pediatr. 136 (1): 69–72. doi:10.1016/S0022-3476(00)90052-0. PMID 10636977.
• Santer R, Kinner M, Passarge M, et al. (2001). "Novel missense mutations outside the allosteric domain of glutamate dehydrogenase are prevalent in European patients with the congenital hyperinsulinism-hyperammonemia syndrome". Hum. Genet. 108 (1): 66–71. doi:10.1007/s004390000432. PMID 11214910.
• Smith TJ, Peterson PE, Schmidt T, et al. (2001). "Structures of bovine glutamate dehydrogenase complexes elucidate the mechanism of purine regulation". J. Mol. Biol. 307 (2): 707–20. doi:10.1006/jmbi.2001.4499. PMID 11254391.
• MacMullen C, Fang J, Hsu BY, et al. (2001). "Hyperinsulinism/hyperammonemia syndrome in children with regulatory mutations in the inhibitory guanosine triphosphate-binding domain of glutamate dehydrogenase". J. Clin. Endocrinol. Metab. 86 (4): 1782–7. doi:10.1210/jc.86.4.1782. PMID 11297618.
• Fang J, Hsu BY, MacMullen CM, et al. (2002). "Expression, purification and characterization of human glutamate dehydrogenase (GDH) allosteric regulatory mutations". Biochem. J. 363 (Pt 1): 81–7. doi:10.1042/0264-6021:3630081. PMC 1222454. PMID 11903050.
• Smith TJ, Schmidt T, Fang J, et al. (2002). "The structure of apo human glutamate dehydrogenase details subunit communication and allostery". J. Mol. Biol. 318 (3): 765–77. doi:10.1016/S0022-2836(02)00161-4. PMID 12054821.
• Banerjee S, Schmidt T, Fang J, et al. (2003). "Structural studies on ADP activation of mammalian glutamate dehydrogenase and the evolution of regulation". Biochemistry. 42 (12): 3446–56. doi:10.1021/bi0206917. PMID 12653548.